This inventor holds 1 USPTO granted patent. Top assignee: Toa Medical Electronics Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Kenji Ito: Innovator in Leukocyte Classification
Introduction
Kenji Ito is a notable inventor based in Kakogawa, Japan. He has made significant contributions to the field of medical technology, particularly in the classification of leukocytes. His innovative work has implications for both clinical diagnostics and research.
Latest Patents
Kenji Ito holds a patent for a "Method for classifying leukocytes and a reagent used therefor." This invention involves reagents that enable the classification and counting of leukocytes while lysing erythrocytes. The reagents contain polyoxyethylene-based surfactants and may include hyperosmotic or hypoosmotic agents and solubilizing agents. One embodiment of the invention features surfactants selected from anionic and nonionic polyoxyethylene-based surfactants with 18-30 repeating oxyethylene units per molecule. Another embodiment contains nonionic polyoxyethylene surfactants with 20-100 repeating oxyethylene units per molecule, which does not utilize saponin or quaternary ammonium compounds. This invention allows for the classification of leukocytes into as many as five types, enabling the detection of abnormal cells when used with particulate analysis flow cytometers employing the RF method and the DC method. Kenji Ito has 1 patent to his name.
Career Highlights
Kenji Ito is associated with Toa Medical Electronics Co., Ltd., where he has contributed to advancements in medical reagents and diagnostic technologies. His work has been instrumental in enhancing the accuracy and efficiency of leukocyte classification.
Collaborations
Kenji Ito has collaborated with notable colleagues Yukio Hamaguchi and Yukio Tsujino. Their combined expertise has furthered the development of innovative solutions in the medical field.
Conclusion
Kenji Ito's contributions to the classification of leukocytes represent a significant advancement in medical diagnostics. His innovative methods and reagents have the potential to improve patient outcomes and enhance research capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile